Table 1 Knowledge gaps addressed by integrating modelling at each development stage.
From: Modelling to inform next-generation medical interventions for malaria prevention and treatment
| Â | Knowledge gaps | Modelling evidence |
|---|---|---|
Clinical trial translation, planning, and design | • Which intervention properties drive effectiveness? • When and what type of evidence to generate? | • Key drivers of impact and early clinical data needed • Parameter range validation and translation to other use-cases • Candidate selection criteria |
Use-case, target population, and setting | • Which use-cases to prioritize given unmet needs and intervention characteristics? • Which use-cases achieve the highest impact? | • Impact and minimum criteria requirements across a range of settings and age groups • Account for clinical evidence to re-evaluate use-cases |
Deployment factors | • How can deployment frequency and timing be optimized? • What is the impact of mixed and layered intervention strategies? | • Scenarios of different strategies across use-cases to identify minimum criteria requirements that optimize effectiveness |
Public health impact | • Does the novel intervention improve the standard of care? • Is the intervention cost-effective? | • Endpoint translation • Direct comparison of different interventions and evaluation periods |